Zafirlukast (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Zafirlukast drug offered from Avera McKennan Hospital. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | zafirlukast |
| SUBSTANCE NAME: | ZAFIRLUKAST |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-06-06 |
| END MARKETING DATE: | 0000-00-00 |
Zafirlukast HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zafirlukast from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2016-06-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-0638_e0b20ee4-2775-47e8-b0b3-45980b0f1aa9 |
| PRODUCT NDC: | 69189-0638 |
| APPLICATION NUMBER: | NDA020547 |
Other ZAFIRLUKAST Pharmaceutical Manufacturers / Labelers:
